Medivizor

Title of notification

Here comes the notification
X
 
icon
colorectal cancer | Clinical Trial | Added May 24, 2019

Looking for participants with stage 2 to 4 rectal cancer to try a new targeted therapy treatment

This phase 2 trial is examining the effectiveness and safety of durvalumab (Imfinzi) in the treatment of advanced rectal cancer that is not prone to genetic abnormalities. The main outcomes to be measured will be tumor response to the treatment and side effects. This trial is being conducted in the US.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Diseases of the colon and rectum | Added May 22, 2019

A comparison between two types of radiation therapy in the treatment of rectal cancer

This study compared the effectiveness of two different types of radiation therapy to treat rectal cancer. Researchers suggested that high-dose endorectal brachytherapy (HDEB) is associated with improved tumor response.

icon
colorectal cancer | Clinical Trial | Added May 20, 2019

Searching for patients with colorectal cancer to test this new treatment combination

This trial is examining the safety and effectiveness of combination therapy with pembrolizumab (Keytruda) and lenvatinib (Lenvima) for advanced or unresponsive colorectal cancer (CRC) and other solid tumors. 

The main outcome to be measured will be the objective response rate (ORR; the percentage of participants who have complete disappearance of tumors) after 2 years.

icon
colorectal cancer | Research | 10 pages | source: Journal of the American Medical Association (JAMA) | Added May 19, 2019

High dose vitamin D supplementation may be associated with improved colorectal cancer outcomes

This study investigated if high-dose vitamin D combined with chemotherapy improves outcomes in patients with metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that high-dose vitamin D was associated with an improved chance of survival.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Critical reviews in oncology/hematology | Added May 16, 2019

Stereotactic body radiotherapy improves treatment response in metastatic colorectal cancer

This study investigated the effectiveness of stereotactic body radiotherapy (SBRT) in metastatic (spread to other parts of the body) colorectal cancer. Researchers suggested that SBRT is associated with improved tumor response and manageable side effects.

icon
colorectal cancer | Clinical Trial | Added Apr 26, 2019

Looking for patients with metastatic colorectal cancer to test a new treatment

This trial is examining the effectiveness and safety of a combined treatment with pembrolizumab (Keytruda) and binimetinib (Mektovi). The main outcome to be measured is the tumor response to the treatment. This trial is recruiting in the United States and Canada.

icon
icon
colorectal cancer | Research | Treatment | 10 pages | source: Medicine | Added Apr 25, 2019

Totally robotic versus robotic-assisted colon cancer surgery

This study investigated the short- and long-term outcomes of totally robotic and robotic-assisted colon surgery in the treatment of colon cancer. Researchers suggested that totally robotic surgery is a safe and effective treatment option for these patients.

icon
colorectal cancer | Clinical Trial | Added Apr 24, 2019

Looking for patients with advanced colorectal cancer to test a new immunotherapy combination

This phase 1/2 trial is examining the effectiveness of durvalumab (Imfinzi) and monalizumab to treat patients with colorectal cancer or other solid tumors. The main outcomes to be measured are tumor response to the treatment and side effects.

icon
colorectal cancer | Clinical Trial | Added Apr 21, 2019

Looking for participants to test a new vaccine to treat advanced colorectal cancer

This trial is examining the effectiveness and toxicity of PolyPEPI1018 vaccine in the treatment of advanced colorectal cancer. The main outcome to be measured is tumor response to the treatment. This trial will be conducted in Italy, and Minnesota, US.

icon
colorectal cancer | Clinical Trial | Added Apr 19, 2019

Looking for participants to test a new treatment combination for advanced colorectal cancer

This trial is examining the effectiveness and safety of treatment with nivolumab (Opdivo) and relatlimab in patients with advanced colorectal cancer. The main outcome to be measured will be tumor response to the treatment. This trial is being conducted in Maryland, US.

View

Category

  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon
  • icon

Was this helpful?